Clin Res Hepatol Gastroenterol
September 2025
Objective: Infliximab is approved for pediatric Crohn's disease (CD) and ulcerative colitis (UC), but is limited in children by its intravenous administration. We evaluated the effectiveness and safety of switching from intravenous to subcutaneous infliximab in pediatric patients with CD/UC.
Methods: Multicenter retrospective cohort study, from January to December 2022 in two pediatric centers, that included CD/UC patients in clinical remission and weighing ≥50 kg, treated with maintenance dose IV IFX.
Background: Antibiotic therapy for neonatal Staphylococcus aureus bacteremia (NSAB) is recommended for at least 14 days. However, this recommendation is based on very limited data. This study aimed to compare NSAB relapses between patients treated for less than 14 days versus 14 days or more in neonatal intensive care units.
View Article and Find Full Text PDFBackground: Although initial clinical presentation of hyperekplexia/startle disease is well known, data regarding long-term clinical outcomes is lacking.
Objectives: We provide a long-term evaluation from clinical and pharmacological perspectives, focusing on neurodevelopmental trajectory.
Methods: Twenty-eight patients from nine French hospitals were included based on clinical diagnosis criteria.
Nat Commun
September 2024
Nephrol Dial Transplant
October 2024
Front Public Health
July 2024
Introduction: Water distribution systems in hotels have been related to outbreaks caused by spp. Certain measures, including disinfection by chlorination, maintaining increased temperatures are usually undertaken to prevent outbreaks. However, these preventive strategies are not always effective, since there are several factors (e.
View Article and Find Full Text PDF